MedPath

LABETALOL HYDROCHLORIDE INJECTION, USP

LABETALOL HYDROCHLORIDE INJECTION, USP

Discontinued
DIN Number

02387468

Drug Class

Human

Market Date

Aug 29, 2012

Company
HC

Mylan Pharmaceuticals ULC

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02387468
AIG Number0116170002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
C07AG01 LABETALOL
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous
AHFS Classification24:24.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

LABETALOL HYDROCHLORIDEActive
Strength: 5 MG / ML
Monograph: LABETALOL HYDROCHLORIDE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.